Private Equity, Venture Capital and Angel Investors

  • Strategic due-diligence for harma (formulation, API and CRO companies)
  • Assessment of Risk rewards of investment in target/candidate companies
  • Investment Opportunity Assessment of sub-sectors including API, formulation and CRO to identify best investment theme
  • Assist to capitalize on opportunities by providing specialized bio-pharma domain knowledge including emerging pharma trends, companies, technologies, biosimilars, healthcare reform, insurance and regulatory laws.
  • Business Evaluation of start-up pharma and biotech companies for Venture Capital and Angel investors
  • Providing business ideas for portfolio companies of Private Equity / Venture Capital

MP Advisors exclusive focus and in-depth understanding of pharma Industry over two decades enables the team to offer advisory services to the pharmaceutical companies engaged in Innovation, manufacturing, formulation of drugs, CROs. Our services also extends to Corporate Investors like Private equities, Venture Capital and Angel Investors. Our proprietary database and acquired domain skills support us in advising Private equity/investors in understanding the risk reward of investing in the pharma sector across the globe-US, Europe, Japan and India.

We integrate the team's knowledge and experience to understand the complex science, dynamic market environment shaped by the regulatory approval process to offer end-to- end solution to our clients which aids them in making timely strategic decisions.

We continuously strive to improve our skill sets and understanding to facilitate our customers to view us as long term strategic partners in their business development.

Our Services

Bio-Pharmaceuticals Formulation
Bio-Pharmaceuticals API
Private Equity, VC & Angel Investors